Building Medical Trust for 200 Years – TEDMED Blog

Building Medical Trust for 200 Years – TEDMED Blog

Facebook
Twitter
LinkedIn


This Information 2020 The subject is create a miracle, We look forward to rallying our communities to embrace the miracles of our time, amazing achievements, incredible possibilities and great potential for the future.Therefore, when the United States Pharmacopeia (USP) decided to celebrate its 200th anniversary With TEDMED. After all, today’s miracles are built on a solid foundation of scientific discovery. Moreover, human beings are especially eager for innovations that can help people around the world live longer and healthier lives. Anticipating that USP will be unveiled at TEDMED in March, we talked with CEO Dr. Ronald T. Piervincenzi to discuss the history of the organization, its current work, and ways to build trust in the future of medicine, supplements, and food .

information: We are very happy that you and USP have joined the TEDMED community, especially at such a landmark milestone-the 200th anniversary of USP.

Ronald T. Piervincenzi: thank you. I am very happy to introduce USP to the audience at TEDMED and look forward to meeting participants in Boston in March.

TM value: What made you choose TEDMED to celebrate this milestone anniversary?

RP: Today, we are observing an unprecedented transformation in the medical field. USP has a history of 200 years and is built on trust and confidence in the healthcare system and anticipation and response to emerging health challenges. Our founders joined in 1820 to protect patients from poor quality medical products. Today’s background is different in scale, geography, method and many other factors. But the value of our work is the same. We are exploring how to build trust in future medical breakthroughs. In the TEDMED community, there are many things we can learn from and interact with as we imagined.

TM value: This is the whole purpose of TEDMED! Let’s dive in. What is the Pharmacopoeia and what is the role of USP?

RP: In short, the Pharmacopoeia is an official publication that lists a series of medicines, and lists the preparation methods, instructions for use, and methods for evaluating the quality of the medicines. The “United States Pharmacopoeia-National Formula” published by USP is the official quality standard for drugs sold in the United States. This standard is also used in more than 140 other countries/regions. USP is a leading independent scientific non-profit organization that cooperates with health and science experts around the world to jointly develop quality standards for medicines, dietary supplements, and food ingredients. Through our standards, advocacy, and capacity building, USP has helped billions of people around the world increase the supply of quality medicines, supplements, and food. As the world becomes smaller and smaller and more closely connected, quality issues affect everyone. Disease spread. Increased resistance. Fake medicine kills. The quality foundation we are building can help meet these and other global health challenges. Whether it is to reduce the prevalence of substandard and inferior drugs, or to help curb antimicrobial resistance, we are committed to protecting the health of people all over the world in 10 sites around the world.

TM value: This seems to be a very modern medical method. Why did the United States need a Pharmacopoeia in 1820?

RP: Today, people believe that American drugs are among the safest in the world, but this is not always the case. In 1820, the United States was a new country. The medicines are made separately by doctors or pharmacists, and they are made using different methods. There are no regulations or, more importantly, no standards to ensure that what you get in one city is the same as in another. The strength, quality, and even characteristics of a drug depend on where it is made. In short, before our establishment in 1820, there was no way to ensure that the content on the drug label was actually the content of the bottle. Our founders-11 independent, forward-looking doctors-worried about the lack of uniformity, and took action to protect patients from inferior drugs. Our three founders are not only doctors, but also U.S. Senators-they are the voices that the United States needs to ensure the quality of the medicines Americans use. They established the “United States Pharmacopeia Convention”, which published the first “United States Pharmacopeia”. Since the establishment of the company, great changes have taken place, but for drugs and other new therapies, setting quality standards is still very important-now our work is more global.

Image courtesy of USP

TM value: The theme of this year’s TEDMED is “The Magical Road”, which explores the changes that are taking place in medicine and healthcare. Is that a theme that resonates with you?

RP: Absolutely. Miracles and scientific discoveries make medical breakthroughs possible. But trust makes them popular. More than 800 independent volunteer scientists contributed their expertise to develop and approve USP standards. They help build trust by setting clear quality expectations for medicines, dietary supplements and foods. In turn, the USP standard can help global manufacturers bring more quality and affordable products to the market, benefiting people all over the world. A recent study by Johns Hopkins University found that, on average, there are 50% more generic manufacturers of drugs with USP public quality standards than drugs without USP public quality standards. The study also found that quality standards help promote drug competition in the United States and reduce prescription drug costs.

Image courtesy of USP

TM value: How can a 200-year-old organization prepare for the future?

RP: New technologies and treatment methods such as precision medicine, digital therapy, 3D printing, immunotherapy, gene and stem cell therapy, and artificial intelligence have emerged or are occurring. As we prepare for major breakthroughs, we must work hard to ensure that trust and quality are built in these advances. Unfortunately, widespread trust is in a precarious position in various departments. Our history tells us that for an innovation to become a widespread reality, quality and trust are critical to its widespread acceptance. USP and hundreds of stakeholder organizations and partners are already working hard to build confidence in future breakthroughs and predict and resolve gaps. We know that when USP public standards are available, we can help manufacturers better adopt new technologies, which can often save a lot of costs.In addition to holding seminars and roundtables on topics such as cell and gene therapy and digital therapy, USP also collaborated with MIT Center for Collective Intelligence And more than 100 leaders from the fields of health and science around the world discussed the role and role that trust will play in shaping people’s health between now and 2040. We will work with the TEDMED 2020 community to explore the findings of this project from the “Trusted Cooperative Laboratory”.

Image courtesy of USP

TM value: We look forward to learning more about Trust CoLab. Before that, what should the TEDMED community know about USP?

RP: I mentioned our volunteer scientists before. I invite members of the TEDMED community who are committed to making the world healthier, scientifically rigorous, and independent of political or private sector work to consider becoming “trustworthy advocates.”They can learn more by visiting our website website Or park in front of the USP lounge in the TEDMED social center.I also encourage everyone to learn more about USP’s past, present and future, as well as other opportunities to work with us www.usp.org/200.

TM value: Thank you, Ron and USP for their best wishes since entering the third century.



Source link

More to explorer

Understanding Key Factors in Accidents

Pedestrian Safety Statistics Pedestrian safety is an urgent concern worldwide, with over 1.3 million people dying in traffic accidents annually. Pedestrians account